Literature DB >> 15649247

Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence.

Shoichiro Tsugane1.   

Abstract

Because gastric cancer is still the most common cancer, its prevention is one of the most important aspects of Japan's cancer control strategy. Observations among Japanese immigrants in the USA and Brazil based on the geographic differences, the trend in cancer incidence with time, and the change in incidence patterns indicate that gastric cancer is closely associated with dietary factors, such as the intake of salt and salted food. In international and intra-Japanese ecological studies, the average salt excretion level, estimated using randomly selected 24-h urine samples in each population, was closely correlated with gastric cancer mortality. Several case-control and cohort studies, including the author's recent works, have shown that a higher intake of some traditional salt-preserved food and salt per se, which was estimated using a validated food-frequency questionnaire, was associated with a risk of gastric cancer. While salted food intake may increase the risk of Helicobacter pylori infection, it can also act synergistically to promote the development of gastric cancer. Based on substantial evidence about the association between salt and salted food intake and the risk of gastric cancer from ecological, case-control, and cohort studies conducted in Japan and other countries, as well as mechanistic plausibility, dietary modification involving less salt and salted food intake is a practical strategy with which to prevent gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15649247     DOI: 10.1111/j.1349-7006.2005.00006.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  91 in total

1.  "A Word can become a Seed": A Lesson Learned about Cultural Humility.

Authors:  Edward Kangsuhp Kim
Journal:  J Cancer Educ       Date:  2016-12       Impact factor: 2.037

2.  Case-control study of dietary pattern and other risk factors for gastric cancer.

Authors:  Ali Nemati; Reza Mahdavi; Abbas Naghizadeh Baghi
Journal:  Health Promot Perspect       Date:  2012-07-01

Review 3.  Role of Helicobacter pylori in gastric cancer: Updates.

Authors:  Jahanarah Khatoon; Ravi Prakash Rai; Kashi Nath Prasad
Journal:  World J Gastrointest Oncol       Date:  2016-02-15

Review 4.  Recognition of and recent issues in hereditary diffuse gastric cancer.

Authors:  Shinya Sugimoto; Hirokazu Komatsu; Yuichi Morohoshi; Takanori Kanai
Journal:  J Gastroenterol       Date:  2015-06-07       Impact factor: 7.527

5.  Seroprevalence of Helicobacter pylori in female Vietnamese immigrants to Korea.

Authors:  Su Jung Baik; Sun Young Yi; Hye Sook Park; Bo Hyun Park
Journal:  World J Gastroenterol       Date:  2012-02-14       Impact factor: 5.742

Review 6.  Clinical proteomics identifies potential biomarkers in Helicobacter pylori for gastrointestinal diseases.

Authors:  Chun-Hao Huang; Shyh-Horng Chiou
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

Review 7.  Diabetes and gastric cancer: the potential links.

Authors:  Chin-Hsiao Tseng; Farn-Hsuan Tseng
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

Review 8.  Pathobiology of Helicobacter pylori-Induced Gastric Cancer.

Authors:  Manuel Amieva; Richard M Peek
Journal:  Gastroenterology       Date:  2015-09-16       Impact factor: 22.682

9.  Individual having a parent with early-onset gastric cancer may need screening at younger age.

Authors:  Hee-Won Kwak; Il Ju Choi; Chan Gyoo Kim; Jong Yeul Lee; Soo-Jeong Cho; Bang Wool Eom; Hong Man Yoon; Jungnam Joo; Keun Won Ryu; Young-Woo Kim
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

10.  Disease association with two Helicobacter pylori duplicate outer membrane protein genes, homB and homA.

Authors:  Monica Oleastro; Rita Cordeiro; Yoshio Yamaoka; Dulciene Queiroz; Francis Mégraud; Lurdes Monteiro; Armelle Ménard
Journal:  Gut Pathog       Date:  2009-06-22       Impact factor: 4.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.